Skip to main content

Table 4 Detailed information analysis of the patients’ sample, with one comorbidity

From: Comorbidities and HCV coinfection in the management of HIV+ patients: evidence from the Italian clinical practice

  HIV+ mono-infected patients
N = 251
HIV/HCV co-infected patients
N = 200
p-value and Chi-squared
Cardiovascular comorbidity Mean Age [y] 53.22 51.80 > 0.050
Male gender 78.05% 84.52% > 0.050
Years with HIV [y] 12.89 23.21 < 0.001
Neurocognitive impairments Mean Age [y] 42.13 50.78 < 0.001
Male gender 97.78% 85.19% 0.042
Years with HIV [y] 7.58 21.63 < 0.001
HBV Mean Age [y] 46.40 50.11 > 0.050
Male gender 100.00% 100.00% NA
Years with HIV [y] 18.40 23.00 > 0.050
Bone events Mean Age [y] 43.43 51.31 < 0.001
Male gender 71.43% 73.77% > 0.050
Years with HIV [y] 10.71 24.95 < 0.001
Renal events Mean Age [y] 41.83 53.75 0.014
Male gender 66.67% 75.00% > 0.050
Years with HIV [y] 11.17 20.75 > 0.050
Diabetes Mean Age [y] 44.33 54.40 0.002
Male gender 100.00% 73.33% > 0.050
Years with HIV [y] 14.00 22.93 > 0.050